Zurich Cantonal Bank’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Buy |
100,338
+16,175
| +19% | +$50K | ﹤0.01% | 1940 |
|
|
2025
Q1 | $294K | Sell |
84,163
-5,502
| -6% | -$19.2K | ﹤0.01% | 1900 |
|
|
2024
Q4 | $293K | Buy |
89,665
+52,162
| +139% | +$171K | ﹤0.01% | 1957 |
|
|
2024
Q3 | $144K | Buy |
37,503
+30,723
| +453% | +$118K | ﹤0.01% | 2277 |
|
|
2024
Q2 | $21K | Sell |
6,780
-101
| -1% | -$312 | ﹤0.01% | 2587 |
|
|
2024
Q1 | $17.8K | Buy |
+6,881
| New | +$17.8K | ﹤0.01% | 2634 |
|
|
2023
Q1 | – | Sell |
-6,178
| Closed | -$14.4K | – | 2856 |
|
|
2022
Q4 | $14.4K | Sell |
6,178
-1,185
| -16% | -$2.76K | ﹤0.01% | 2786 |
|
|
2022
Q3 | $14K | Hold |
7,363
| – | – | ﹤0.01% | 2841 |
|
|
2022
Q2 | $20K | Sell |
7,363
-745
| -9% | -$2.02K | ﹤0.01% | 2795 |
|
|
2022
Q1 | $24K | Buy |
+8,108
| New | +$24K | ﹤0.01% | 2647 |
|